SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-51.11%
Change (1 year)
Categories
SCYNEXIS (SCYX) - P/B ratio
P/B ratio as of April 2024 : 0.6320
According to SCYNEXIS's latest financial reports the company has a price-to-book ratio of 0.6320.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
SCYNEXIS - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 1.14 | -92.78% |
| 2022-12-31 | 15.8 | 345.01% |
| 2021-12-31 | 3.54 | -45.36% |
| 2020-12-31 | 6.48 | -5.72% |
| 2019-12-31 | 6.87 | 828.92% |
| 2018-12-31 | 0.7401 | -76.09% |
| 2017-12-31 | 3.09 | 40.8% |
| 2016-12-31 | 2.20 | 6.77% |
| 2015-12-31 | 2.06 | -18.99% |
| 2014-12-31 | 2.54 | |
| 2013-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | 0.1514 | -76.05% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | 4.53 | 616.78% | 🇺🇸 USA |
 Catalent CTLT | 2.74 | 334.29% | 🇺🇸 USA |
 KemPharm KMPH | 2.34 | 269.66% | 🇺🇸 USA |